Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization.

Drug Deliv · 2018 · PMC6058521 · PMID 29869520

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < .01actually significant

Statistically significant differences were set as p < .05 and highly significant differences were set as p < .01.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.